{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:16:02Z","timestamp":1791922562890,"version":"4.3.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s11739-025-03893-8","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T17:43:49Z","timestamp":1740073429000},"page":"1003-1012","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Demographic and regional trends in systemic and cardiovascular amyloidosis-related mortality among older adults in the United States from 1999 to 2020"],"prefix":"10.1007","volume":"20","author":[{"given":"Jasninder Singh","family":"Dhaliwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7905-4133","authenticated-orcid":false,"given":"Fatima","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamza","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeer T. M. A.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah Aslam","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha Asghar","family":"Memon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha","family":"Arshad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayed Maisum","family":"Mehdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anum Touseef","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha Ali","family":"Rind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syeda Umbreen","family":"Munir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilal","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kashaf","family":"Nadeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Mustafa","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,20]]},"reference":[{"issue":"3","key":"3893_CR1","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1080\/13506129.2019.1618261","volume":"26","author":"N Patil","year":"2019","unstructured":"Patil N, Arora S, Qamar A, Strassle PD, Alexander KM, Fatima A, Maurer MS et al (2019) Trends and causes of hospitalizations in patients with amyloidosis. Amyloid 26(3):177\u2013178. https:\/\/doi.org\/10.1080\/13506129.2019.1618261","journal-title":"Amyloid"},{"issue":"2","key":"3893_CR2","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.coph.2005.10.005","volume":"6","author":"HJ Lachmann","year":"2006","unstructured":"Lachmann HJ, Hawkins PN (2006) Systemic amyloidosis. Curr Opin Pharmacol 6(2):214\u2013220. https:\/\/doi.org\/10.1016\/j.coph.2005.10.005","journal-title":"Curr Opin Pharmacol"},{"issue":"4","key":"3893_CR3","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1365-3083.1979.tb0i1355.x","volume":"10","author":"P Westermark","year":"1979","unstructured":"Westermark P, Johansson B, Natvig JB (1979) Senile cardiac amyloidosis: evidence of two different amyloid substances in the ageing heart. Scand J Immunol 10(4):303\u2013308. https:\/\/doi.org\/10.1111\/j.1365-3083.1979.tb0i1355.x","journal-title":"Scand J Immunol"},{"issue":"11","key":"3893_CR4","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.jchf.2019.07.007","volume":"7","author":"CD Barrett","year":"2019","unstructured":"Barrett CD, Dobos K, Liedtke M, Tuzovic M, Haddad F, Kobayashi Y, Lafayette R, Fowler MB, Arai S, Schrier S, Witteles RM (2019) A changing landscape of mortality for systemic light chain amyloidosis. JACC Heart Fail 7(11):958\u2013966. https:\/\/doi.org\/10.1016\/j.jchf.2019.07.007","journal-title":"JACC Heart Fail"},{"issue":"3","key":"3893_CR5","doi-asserted-by":"publisher","first-page":"329","DOI":"10.6004\/jadpro.2021.12.3.24","volume":"12","author":"B Faiman","year":"2021","unstructured":"Faiman B, Richards T (2021) Diagnosis and treatment of AL and ATTR amyloidosis. J Adv Pract Oncol 12(3):329\u2013332. https:\/\/doi.org\/10.6004\/jadpro.2021.12.3.24","journal-title":"J Adv Pract Oncol"},{"issue":"1","key":"3893_CR6","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s00392-019-01490-2","volume":"109","author":"F Escher","year":"2020","unstructured":"Escher F, Senoner M, Doerler J, Zaruba MM, Messner M, Mussner-Seeber C, Ebert M, Ensinger C, Mair A, Kroiss A, Ulmer H, Schneiderbauer-Porod S, Ebner C, Poelzl G (2020) When and how do patients with cardiac amyloidosis die? Clin Res Cardiol 109(1):78\u201388. https:\/\/doi.org\/10.1007\/s00392-019-01490-2","journal-title":"Clin Res Cardiol"},{"issue":"10038","key":"3893_CR7","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1016\/S0140-6736(15)01274-X","volume":"387","author":"AD Wechalekar","year":"2016","unstructured":"Wechalekar AD, Gillmore JD, Hawkins PN (2016) Systemic amyloidosis. Lancet 387(10038):2641\u20132654. https:\/\/doi.org\/10.1016\/S0140-6736(15)01274-X","journal-title":"Lancet"},{"issue":"1","key":"3893_CR8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1159\/000444206","volume":"2","author":"HL Nienhuis","year":"2016","unstructured":"Nienhuis HL, Bijzet J, Hazenberg BP (2016) The prevalence and management of systemic amyloidosis in western countries. Kidney Dis (Basel) 2(1):10\u201319. https:\/\/doi.org\/10.1159\/000444206","journal-title":"Kidney Dis (Basel)"},{"issue":"9","key":"3893_CR9","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1001\/jamacardio.2018.2093","volume":"3","author":"KM Alexander","year":"2018","unstructured":"Alexander KM, Orav J, Singh A, Jacob SA, Menon A, Padera RF, Kijewski MF, Liao R, Di Carli MF, Laubach JP, Falk RH, Dorbala S (2018) Geographic disparities in reported US amyloidosis mortality from 1979 to 2015: potential underdetection of cardiac amyloidosis. JAMA Cardiol 3(9):865\u2013870. https:\/\/doi.org\/10.1001\/jamacardio.2018.2093","journal-title":"JAMA Cardiol"},{"issue":"4","key":"3893_CR10","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s11897-024-00669-7","volume":"21","author":"J Vogel","year":"2024","unstructured":"Vogel J, Carpinteiro A, Luedike P et al (2024) Current therapies and future horizons in cardiac amyloidosis treatment. Curr Heart Fail Rep 21(4):305\u2013321. https:\/\/doi.org\/10.1007\/s11897-024-00669-7","journal-title":"Curr Heart Fail Rep"},{"key":"3893_CR11","doi-asserted-by":"crossref","unstructured":"Overview of amyloidosis. UpToDate, https:\/\/www.uptodate.com\/contents\/overview-of-amyloidosis. Accessed 15 Apr 2024","DOI":"10.1097\/01.EEM.0001011648.95998.10"},{"key":"3893_CR12","unstructured":"Centers for Disease Control and Prevention, National Center for Health Statistics. Multiple cause of death 1999\u20132019 on CDC WONDER online database. Data are from the Multiple Cause of Death Files, 1999\u20132020, as compiled from data provided by the 57 vital statistics jurisdictions through the Vital Statistics Cooperative Program. Available at: http:\/\/wonder.cdc.gov\/mcd-icd10.html. Accessed 20 Mar 2024"},{"issue":"7","key":"3893_CR13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.41432","volume":"15","author":"OE Okobi","year":"2023","unstructured":"Okobi OE, Beeko PKA, Nikravesh E, Beeko MAE, Ofiaeli C, Ojinna BT et al (2023) Trends in obesity-related mortality and racial disparities. Cureus 15(7):e41432. https:\/\/doi.org\/10.7759\/cureus.41432","journal-title":"Cureus"},{"key":"3893_CR14","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000001929","author":"S Ma","year":"2023","unstructured":"Ma S, Sokale IO, Thrift AP (2023) Trends and variations in pancreatic cancer mortality among US metro and nonmetro adults, 1999\u20132020. J Clin Gastroenterol. https:\/\/doi.org\/10.1097\/MCG.0000000000001929","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"3893_CR15","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1186\/s12916-023-03143-8","volume":"21","author":"N Mostafa","year":"2023","unstructured":"Mostafa N, Sayed A, Rashad O, Baqal O (2023) Malnutrition-related mortality trends in older adults in the United States from 1999 to 2020. BMC Med 21(1):421. https:\/\/doi.org\/10.1186\/s12916-023-03143-8","journal-title":"BMC Med"},{"key":"3893_CR16","unstructured":"Inclusion Across the Lifespan in Human Subjects Research Policy SOP. National Institute of Allergy and Infectious Disease. 2025. https:\/\/www.niaid.nih.gov\/research\/inclusion-across-lifespan-human-subjects-research-policy-sop#procedure. Accessed 27 Jan 2025"},{"key":"3893_CR17","unstructured":"Ingram DD, Franco SJ (2014) 2013 NCHS urban-rural classification scheme for counties. US Department of Health and Human Services, Centers for Disease Control and Prevention"},{"issue":"3","key":"3893_CR18","first-page":"1","volume":"47","author":"RN Anderson","year":"1998","unstructured":"Anderson RN, Rosenberg HM (1998) Age standardization of death rates: implementation of the year 2000 standard. Natl Vital Stat Rep 47(3):1\u201316","journal-title":"Natl Vital Stat Rep"},{"issue":"14","key":"3893_CR19","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1001\/jama.2022.2896","volume":"327","author":"V Parcha","year":"2022","unstructured":"Parcha V, Malla G, Irvin MR, Armstrong ND, Judd SE, Lange LA et al (2022) Association of transthyretin Val122Ile variant with incident heart failure among black individuals. JAMA 327(14):1368\u20131378. https:\/\/doi.org\/10.1001\/jama.2022.2896. (Erratum.In:JAMA.2022May10;327(18):1825)","journal-title":"JAMA"},{"key":"3893_CR20","unstructured":"IAEA Transthyretin Amyloid Cardiomyopathy Study\u2014The I-TAC study. IAEA. https:\/\/www.iaea.org\/projects\/crp\/e13055. Accessed 30 July 2021"},{"issue":"10","key":"3893_CR21","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3238\/arztebl.2020.0159","volume":"117","author":"S Ihne","year":"2020","unstructured":"Ihne S, Morbach C, Sommer C, Geier A, Knop S, St\u00f6rk S (2020) Amyloidosis-the diagnosis and treatment of an underdiagnosed disease. Dtsch Arztebl Int 117(10):159\u2013166. https:\/\/doi.org\/10.3238\/arztebl.2020.0159","journal-title":"Dtsch Arztebl Int"},{"issue":"1","key":"3893_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1182\/asheducation-2017.1.1","volume":"2017","author":"G Merlini","year":"2017","unstructured":"Merlini G (2017) AL amyloidosis: from molecular mechanisms to targeted therapies. Hematol Am Soc Hematol Educ Program 2017(1):1\u201312. https:\/\/doi.org\/10.1182\/asheducation-2017.1.1","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"15","key":"3893_CR23","doi-asserted-by":"publisher","first-page":"117954682110152","DOI":"10.1177\/11795468211015230","volume":"29","author":"J Nativi-Nicolau","year":"2021","unstructured":"Nativi-Nicolau J, Sarswat N, Fajardo J, Finkel M, Abdulsattar Y, Casta\u00f1o A, Klein L, Haddad-Angulo A (2021) Best practices in specialized amyloidosis centers in the United States: a survey of cardiologists, nurses, patients, and patient advocates. Clin Med Insights Cardiol 29(15):11795468211015230. https:\/\/doi.org\/10.1177\/11795468211015230","journal-title":"Clin Med Insights Cardiol"},{"issue":"6","key":"3893_CR24","doi-asserted-by":"publisher","first-page":"e005407","DOI":"10.1161\/CIRCHEARTFAILURE.118.005407","volume":"12","author":"LG Gilstrap","year":"2019","unstructured":"Gilstrap LG, Dominici F, Wang Y, El-Sady MS, Singh A, Di Carli MF, Falk RH, Dorbala S (2019) Epidemiology of cardiac amyloidosis-associated heart failure hospitalizations among fee-for-service medicare beneficiaries in the United States. Circ Heart Fail 12(6):e005407. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.118.005407","journal-title":"Circ Heart Fail"},{"issue":"4","key":"3893_CR25","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1007\/s11136-021-02943-w","volume":"31","author":"A D'Souza","year":"2022","unstructured":"D\u2019Souza A, Myers J, Cusatis R, Dispenzieri A, Finkel M, Panepinto J, Flynn KE (2022) Development of a conceptual model of patient-reported outcomes in light chain amyloidosis: a qualitative study. Qual Life Res 31(4):1083\u20131092. https:\/\/doi.org\/10.1007\/s11136-021-02943-w","journal-title":"Qual Life Res"},{"issue":"3","key":"3893_CR26","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s40119-022-00265-7","volume":"11","author":"CM Campbell","year":"2022","unstructured":"Campbell CM, LoRusso S, Dispenzieri A, Kristen AV, Maurer MS, Rapezzi C et al (2022) Sex differences in wild-type transthyretin amyloidosis: an analysis from the transthyretin amyloidosis outcomes survey (THAOS). Cardiol Ther 11(3):393\u2013405. https:\/\/doi.org\/10.1007\/s40119-022-00265-7","journal-title":"Cardiol Ther"},{"issue":"11","key":"3893_CR27","doi-asserted-by":"publisher","first-page":"6126","DOI":"10.3390\/ijerph18116126","volume":"18","author":"R Grazuleviciene","year":"2021","unstructured":"Grazuleviciene R, Andrusaityte S, D\u0117del\u0117 A, Grazulevicius T, Valius L, Rapalavicius A et al (2021) Urban environment and health: a cross-sectional study of the influence of environmental quality and physical activity on blood pressure. Int J Environ Res Public Health 18(11):6126. https:\/\/doi.org\/10.3390\/ijerph18116126","journal-title":"Int J Environ Res Public Health"},{"key":"3893_CR28","unstructured":"Men will do Almost Anything to Avoid Going to the Doctor. Cleveland Clinic. 2019. https:\/\/newsroom.clevelandclinic.org\/2019\/09\/04\/cleveland-clinic-survey-men-will-do-almost-anything-to-avoid-going-to-the-doctor. Accessed 24 Jul 2024"},{"issue":"3","key":"3893_CR29","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s10741-024-10386-x","volume":"29","author":"A Aimo","year":"2024","unstructured":"Aimo A, Morfino P, Arzilli C, Vergaro G, Spini V, Fabiani I, Castiglione V, Rapezzi C, Emdin M (2024) Disease features and management of cardiomyopathies in women. Heart Fail Rev 29(3):663\u2013674. https:\/\/doi.org\/10.1007\/s10741-024-10386-x","journal-title":"Heart Fail Rev"},{"issue":"1","key":"3893_CR30","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s13023-022-02414-6","volume":"17","author":"N Kumar","year":"2022","unstructured":"Kumar N, Zhang NJ, Cherepanov D, Romanus D, Hughes M, Faller DV (2022) Global epidemiology of amyloid light-chain amyloidosis. Orphanet J Rare Dis 17(1):278. https:\/\/doi.org\/10.1186\/s13023-022-02414-6","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"3893_CR31","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1002\/ehf2.12518","volume":"6","author":"H Yamamoto","year":"2019","unstructured":"Yamamoto H, Yokochi T (2019) Transthyretin cardiac amyloidosis: an update on diagnosis and treatment. ESC Heart Fail 6(6):1128\u20131139. https:\/\/doi.org\/10.1002\/ehf2.12518","journal-title":"ESC Heart Fail"},{"issue":"1","key":"3893_CR32","doi-asserted-by":"publisher","first-page":"12","DOI":"10.4065\/mcp.2010.0480","volume":"86","author":"SK Kumar","year":"2011","unstructured":"Kumar SK, Gertz MA, Lacy MQ, Dingli D, Hayman SR, Buadi FK, Short-Detweiler K, Zeldenrust SR, Leung N, Greipp PR, Lust JA, Russell SJ, Kyle RA, Rajkumar SV, Dispenzieri A (2011) Recent improvements in survival in primary systemic amyloidosis and the importance of an early mortality risk score. Mayo Clin Proc 86(1):12\u201318. https:\/\/doi.org\/10.4065\/mcp.2010.0480","journal-title":"Mayo Clin Proc"},{"issue":"11","key":"3893_CR33","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s12471-019-1299-1","volume":"27","author":"MIFJ Oerlemans","year":"2019","unstructured":"Oerlemans MIFJ, Rutten KHG, Minnema MC, Raymakers RAP, Asselbergs FW, de Jonge N (2019) Cardiac amyloidosis: the need for early diagnosis. Neth Heart J 27(11):525\u2013536. https:\/\/doi.org\/10.1007\/s12471-019-1299-1","journal-title":"Neth Heart J"},{"issue":"4","key":"3893_CR34","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s11739-022-02958-2","volume":"17","author":"F Perfetto","year":"2022","unstructured":"Perfetto F, Zampieri M, Fumagalli C, Allinovi M, Cappelli F (2022) Circulating biomarkers in diagnosis and management of cardiac amyloidosis: a review for internist. Intern Emerg Med 17(4):957\u2013969. https:\/\/doi.org\/10.1007\/s11739-022-02958-2","journal-title":"Intern Emerg Med"},{"issue":"9","key":"3893_CR35","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1093\/ndt\/gfy291","volume":"34","author":"R Ry\u0161av\u00e1","year":"2019","unstructured":"Ry\u0161av\u00e1 R (2019) AL amyloidosis: advances in diagnostics and treatment. Nephrol Dial Transplant 34(9):1460\u20131466. https:\/\/doi.org\/10.1093\/ndt\/gfy291","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"3893_CR36","doi-asserted-by":"publisher","first-page":"59","DOI":"10.14797\/mdcvj.1050","volume":"18","author":"LK Stern","year":"2022","unstructured":"Stern LK, Patel J (2022) Cardiac amyloidosis treatment. Methodist Debakey Cardiovasc J 18(2):59\u201372. https:\/\/doi.org\/10.14797\/mdcvj.1050","journal-title":"Methodist Debakey Cardiovasc J"},{"issue":"17","key":"3893_CR37","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1056\/NEJMoa2300757","volume":"389","author":"MS Maurer","year":"2023","unstructured":"Maurer MS, Kale P, Fontana M et al (2023) Patisiran treatment in patients with transthyretin cardiac amyloidosis. N Engl J Med 389(17):1553\u20131565. https:\/\/doi.org\/10.1056\/NEJMoa2300757","journal-title":"N Engl J Med"},{"issue":"7","key":"3893_CR38","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.3390\/jcm12072581","volume":"12","author":"N Laptseva","year":"2023","unstructured":"Laptseva N, Rossi VA, Sudano I, Schwotzer R, Ruschitzka F, Flammer AJ et al (2023) Arrhythmic manifestations of cardiac amyloidosis: challenges in risk stratification and clinical management. J Clin Med 12(7):2581. https:\/\/doi.org\/10.3390\/jcm12072581","journal-title":"J Clin Med"},{"issue":"10","key":"3893_CR39","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1002\/ejhf.2684","volume":"24","author":"J Butler","year":"2022","unstructured":"Butler J, Siddiqi TJ, Anker SD (2022) Patiromer use in patients with heart failure: lessons and clinical considerations from the DIAMOND trial. Eur J Heart Fail 24(10):1744\u20131747. https:\/\/doi.org\/10.1002\/ejhf.2684","journal-title":"Eur J Heart Fail"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-025-03893-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11739-025-03893-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-025-03893-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T12:04:32Z","timestamp":1748865872000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11739-025-03893-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,20]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["3893"],"URL":"https:\/\/doi.org\/10.1007\/s11739-025-03893-8","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,20]]},"assertion":[{"value":"8 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose. The authors have no conflicts of interest to declare that are relevant to the content of this article. All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript. The authors have no financial or proprietary interests in any material discussed in this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was exempt from local institutional review board approval because it used deidentified public data and adhered to STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}